Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US8222239B2 · kind B2 · utility
5Cited by
95References
47Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 21, 2008 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | Aug 11, 2028 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, a bridged polycyclic compound may be pharmaceutically active. In some embodiments, a bridged polycyclic compound may be function as a carrier for pharmaceutically active agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.